Keuck Lara
Department of History, Humboldt-Universität zu Berlin, Unter den Linden 6, 10099, Berlin, Germany.
Hist Philos Life Sci. 2017 Nov 27;40(1):10. doi: 10.1007/s40656-017-0177-7.
This paper examines medical scientists' accounts of their rediscoveries and reassessments of old materials. It looks at how historical patient files and brain samples of the first cases of Alzheimer's disease became reused as scientific objects of inquiry in the 1990s, when a genetic neuropathologist from Munich and a psychiatrist from Frankfurt lead searches for left-overs of Alzheimer's 'founder cases' from the 1900s. How and why did these researchers use historical methods, materials and narratives, and why did the biomedical community cherish their findings as valuable scientific facts about Alzheimer's disease? The paper approaches these questions by analysing how researchers conceptualised 'history' while backtracking and reassessing clinical and histological materials from the past. It elucidates six ways of conceptualising history as a biomedical matter: (1) scientific assessments of the past, i.e. natural scientific understandings of 'historical facts'; (2) history in biomedicine, e.g. uses of old histological collections in present day brain banks; (3) provenance research, e.g. applying historical methods to ensure the authenticity of brain samples; (4) technical biomedical history, e.g. reproducing original staining techniques to identify how old histological slides were made; (5) founding traditions, i.e. references to historical objects and persons within founding stories of scientific communities; and (6) priority debates, e.g. evaluating the role particular persons played in the discovery of a disease such as Alzheimer's. Against this background, the paper concludes with how the various ways of using and understanding 'history' were put forward to re-present historic cases as 'proto-types' for studying Alzheimer's disease in the present.
本文考察了医学科学家对其重新发现和重新评估旧材料的描述。它探讨了20世纪90年代,当一位来自慕尼黑的基因神经病理学家和一位来自法兰克福的精神病学家带头寻找20世纪阿尔茨海默病“奠基病例”的遗留物时,历史患者档案和阿尔茨海默病首例病例的脑样本是如何被重新用作科学研究对象的。这些研究人员如何以及为何使用历史方法、材料和叙述,生物医学领域又为何将他们的发现视为关于阿尔茨海默病的宝贵科学事实?本文通过分析研究人员在回溯和重新评估过去的临床和组织学材料时如何将“历史”概念化来探讨这些问题。它阐明了将历史概念化为生物医学问题的六种方式:(1)对过去的科学评估,即对“历史事实”的自然科学理解;(2)生物医学中的历史,例如当今脑库中对旧组织学标本的使用;(3)出处研究,例如应用历史方法确保脑样本的真实性;(4)生物医学技术史,例如重现原始染色技术以确定旧组织学切片的制作方法;(5)开创传统,即在科学共同体的开创故事中提及历史对象和人物;(6)优先权辩论,例如评估特定人物在诸如阿尔茨海默病等疾病发现中所起的作用。在此背景下,本文最后阐述了如何通过提出使用和理解“历史”的各种方式,将历史病例重新呈现为当下研究阿尔茨海默病的“原型”。